Health

The Commercialization Gap Is Real: Rapid Infection Diagnostics Shows Why Early Investment Matters   For most startups, securing enough capital to move from research to commercialization is one of the greatest challenges they will face. For Alberta-based Rapid Infection Diagnostics Inc. (RID), that journey has taken more than a decade, required nearly $20 million in […]

Genomic tools and technologies have the potential to improve our health, environment and nutrition, and Alberta has no shortage of entrepreneurs ready to meet the challenge. However, while biotech startups are typically well-equipped to test and refine their technologies and products, scaling-up into a sustainable business presents a wholly new challenge. A 2025 survey conducted

From Lab Discovery to Global Impact: How Nova Medical Testing Inc. is Advancing Metabolomics in Alberta and Beyond   In the world of life sciences, timing is everything. While genomics can help predict what might happen in the body, metabolomics reveals what has already happened and provides a powerful perspective that is becoming increasingly important

As data becomes the engine driving modern discovery, Dr. David Wishart stands at the forefront in building the datasets and AI tools that use information to power innovation. A globally recognized leader in metabolomics and precision health, Dr. Wishart was honoured with the ASTech Award in the AI/ML Advancement and Application category, for his groundbreaking